SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53

Bladder cancer (BCa) is one of the most common malignancies worldwide. However, the lack of accurate and effective targeted drugs has become a major problem in current clinical treatment of BCa. Studies have demonstrated that squalene epoxidase (SQLE), as a key rate-limiting enzyme in cholesterol bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Fan, Chen, Wu, Song, Tianbao, Xing, Ji, Zhang, Yunlong, Chen, Kang, Hu, Weimin, Li, Linzhi, Ning, Jinzhuo, Li, Chenglong, Yu, Weimin, Cheng, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540347/
https://www.ncbi.nlm.nih.gov/pubmed/37770925
http://dx.doi.org/10.1186/s12935-023-02997-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540347/
https://www.ncbi.nlm.nih.gov/pubmed/37770925
http://dx.doi.org/10.1186/s12935-023-02997-5

Ejemplares similares